The incidence of AIDS-defining cancers (ADCs)–Kaposi sarcoma, primary central nervous
system lymphoma, non-Hodgkin lymphoma, and cervical cancer–although on the decline …

Since the advent of HAART, patients with HIV infection have seen a significant improvement
in their morbidity, mortality, and life expectancy. The incidence of AIDS-defining illnesses …

Background: Cancer is increasingly common among persons with HIV. Objective: To
examine calendar trends in cumulative cancer incidence and hazard rate by HIV status …

Background: Persons who are HIV-infected may be at higher risk for certain types of cancer
than the general population. Objective: To compare cancer incidence among HIV-infected …

Background: Monitoring the full spectrum of causes of death among persons with AIDS is
increasingly important as survival improves because of highly active antiretroviral therapy …

Purpose The effect of highly active antiretroviral therapy (HAART) on the incidence of non–
AIDS-defining cancers (NADCs) is unclear. Methods We have investigated the occurrence of …

Objective: To describe trends in incidence rates of AIDS-defining cancers (ADCs) and non-
AIDS-defining cancers (NADCs) during the HIV epidemic and to evaluate predictors …

BACKGROUND The objective of this study was to determine the rates and predictors of non‐
AIDS‐defining cancers (NADCs) among a cohort of human immunodeficiency virus (HIV) …

Background: The incidence of non-AIDS-defining malignancies (non-ADMs) is reported as
unchanged or increasing in the highly active antiretroviral therapy era. Whether incidence of …

Background Mortality in HIV-infected patients has declined substantially with combination
antiretroviral therapy (ART), but it is unclear whether it has reached that of the general …